Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study of Safety and Immunogenicity in Subjects Following Injection With Two Doses of HEPLISAV™

NCT00511095 is registered in ClinicalTrials.gov with Dynavax Technologies Corporation as lead sponsor.

NCT NCT00511095
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00511095 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study of Safety and Immunogenicity in Subjects Following Injection With Two Doses of HEPLISAV™
Lead sponsor
Dynavax Technologies Corporation
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2007
Completion date
March 31, 2008
Enrollment
207 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b